IC Value
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

Lipid peroxidation and antioxidants during treatment of hepatitis -B with phyllanthus amarus

Authors:Padmaja S. Nikam , Shashikant V. Nikam , Ajit V. Sontakke
Int J Biol Med Res. 2010; 1(3): 41 - 43  |  PDF File

Abstract

ABSTRACT Hepatitis-B is a global public health problem in India, and responsible for major chunk of morbidity and mortality. The present study focuses on effect of phyllanthus amarus therapy for protection of liver in hepatitis-B through investigating liver profile enzymes, antioxidant enzymes, antioxidant vitamins and lipid peroxidation. The study consists of 65 clinical diagnosed hepatitis-B patients ranging in between age group 25-60 years. The control group includes 65 ages and sex matched normal healthy persons. Oxidative stress was assessed by estimating lipid peroxides as MDA. The parameters like serum bilirubin, total proteins and activity of liver profile enzymes were done. Activity of enzymatic antioxidants, superoxide dismutase [SOD], glutathione peroxides [GPx], catalase and levels of non-enzymatic antioxidant vitamin E and vitamin C was measured in plasma or erythrocytes. Methods used in the study are mainly enzyme kinetics by auto analyzer and by turbidimetry. Plasma LPO levels were significantly high but activity of SOD, GPx, catalase and levels of vitamin E and vitamin C were significantly lowered in hepatitis- B on comparison with controls. After phyllanthus amarus therapy for 4 weeks and 8 weeks plasma LPO levels were significantly decreased and activity of SOD, GPx, catalase and vitamin E and vitamin C were significantly increased in hepatitis-B. The present study concludes that, hepatitis-B increases oxidative stress and may be playing an important role in hepatic cell damage and pathogenesis of hepatitis-B. This study strongly suggests that the therapy with phyllanthus amarus increases antioxidants and reduces lipid peroxidation of hepatic cellular and intracellular membranes and protects liver damage due to free radicals in hepatitis-B.